NDC 58160-820-43 - ENGERIX-B
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 58160-820
- Requested NDC
- 58160-820-43
- Package NDCs from labels
- 58160-820-43, 58160-820-52
- Manufacturer
- GlaxoSmithKline Biologicals SA
- Effective date
- 2026-05-14
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| ENGERIX-B - GlaxoSmithKline Biologicals SA | GlaxoSmithKline Biologicals SA | 2026-05-14 | VACCINE LABEL |
| ENGERIX-B - A-S Medication Solutions | A-S Medication Solutions | 2020-01-18 | VACCINE LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 58160-820-43 | ENGERIX-B | 0.5 mL in 1 SYRINGE | INJECTION, SUSPENSION | 0.5 | 34 | |
| 58160-820-52 | ENGERIX-B | 10 in 1 CARTON | INJECTION, SUSPENSION | 10 | 34 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 58160-820-01 | ML - Milliliter | 58160-820 | af919af3-adb6-4f20-bd16-28e48544b134 | 1 | 2017-04-05 |
| 58160-820-11 | ML - Milliliter | 58160-820 | 6f9daaa0-bfee-4d44-ae2b-98aea559f495 | 1 | 2013-02-13 |
| 58160-820-43 | ML - Milliliter | 58160-820 | 7012f0c1-e974-4f20-ae3b-9a1f737530bd | 1 | 2015-07-20 |
| 58160-820-52 | ML - Milliliter | 58160-820 | 2aa3cd2c-f03a-4732-a589-ed2f8b62db01 | 1 | 2013-02-13 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Isolyte S pH 7.4 | SODIUM CHLORIDE, SODIUM GLUCONATE, SODIUM ACETATE, POTASSIUM CHLORIDE, MAGNESIUM CHLORIDE, SODIUM PHOSPHATE, DIBASIC, AND POTASSIUM PHOSPHATE | B. Braun Medical Inc. | 150437b6-320e-4c69-a434-2a26a1f0b2e4 | 2026-10-12 | Warnings, Adverse reactions | 451W47IQ8X |
| Isolyte S | SODIUM CHLORIDE, SODIUM GLUCONATE, SODIUM ACETATE, POTASSIUM CHLORIDE, AND MAGNESIUM CHLORIDE | B. Braun Medical Inc. | 7e8fe27f-ff82-48c1-9bf6-3c589c8e985d | 2026-10-12 | Warnings, Adverse reactions | 451W47IQ8X |
| Sodium Chloride | SODIUM CHLORIDE | CODAN US CORPORATION | aa06e286-75c6-4d7a-959f-6008d38aa6e5 | 2026-10-08 | Warnings, Adverse reactions | 451W47IQ8X |
| GoLYTELY | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE | Braintree Laboratories, Inc. | 57d22b0b-1ae0-4203-babc-f3bac17bd1c9 | 2026-10-08 | Warnings, Adverse reactions | 451W47IQ8X |
| PEG-3350 and Electrolytes | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE | Affordable Pharmaceuticals, LLC | 448db7a5-1fea-4bf3-b1f5-e9d027a36603 | 2026-10-08 | Warnings, Adverse reactions | 451W47IQ8X |
| PEG-3350, sodium chloride, sodium bicarbonate and potassium chloride | POLYETHYLENE GLYCOL 3350, SODIUM CHLORIDE, SODIUM BICARBONATE, POTASSIUM CHLORIDE | Affordable Pharmaceuticals, LLC | 89ca6d56-527a-4be2-baea-531156f0a7be | 2026-10-08 | Warnings, Adverse reactions | 451W47IQ8X |
| Sodium Chloride | SODIUM CHLORIDE | Nextgen Pharmaceuticals LLC | 28f79c75-82d2-4912-81fc-a723b5ccf4c1 | 2026-10-08 | Warnings, Adverse reactions | 451W47IQ8X |
| Sodium Chloride | SODIUM CHLORIDE | SOLA Pharmaceuticals, LLC | 4d0bfd28-460a-48ba-bd17-cf75e56d62f4 | 2026-10-08 | Warnings, Adverse reactions | 451W47IQ8X |
| Sodium Chloride | SODIUM CHLORIDE | LABORATORIOS GRIFOLS SA | eb811d79-fdb8-1f1a-c2ad-1cc4bfc7eadf | 2026-10-08 | Warnings, Adverse reactions | 451W47IQ8X |
| MEIJER Saline | NASAL | MEIJER | a5c6d800-078a-4b66-9d4c-cf3c53f5c138 | 2026-10-05 | Warnings | 451W47IQ8X |
| Personal CARE Saline Nasal | SODIUM CHLORIDE | Delta Brands Inc. | 5ccaf7a1-6891-eac4-e063-6294a90a829f | 2026-10-02 | Warnings | 451W47IQ8X |
| Meijer Extra Strength Original Flavor | ALUMINUM HYDROXIDE AND MAGNESIUM CARBONATE | MEIJER DISTRIBUTION INC | 684708e8-206e-4c26-8be0-3e86428fedb1 | 2026-09-29 | Warnings | 5QB0T2IUN0 |
| Dextrose And Sodium Chloride | DEXTROSE AND SODIUM CHLORIDE | B. Braun Medical Inc. | 8e6569ce-9714-497f-a94b-c6975c1d76f6 | 2026-09-28 | Warnings, Adverse reactions | 451W47IQ8X |
| Mintox Plus Tabs | ALUMINUM HYDROXIDE, MAGNESIUM HYDROXIDE, SIMETHICONE | Major Pharmaceuticals | c72f0736-ee20-45b4-baf0-b80f1e3fa9cb | 2026-09-24 | Warnings | 5QB0T2IUN0 |
| Acid Gone Antacid Extra Strength | ALUMINUM HYDROXIDE AND MAGNESIUM CARBONATE | Major Pharmaceuticals | 4498104a-e41d-41d9-9aed-01904d91af87 | 2026-09-24 | Warnings | 5QB0T2IUN0 |
| Sodium Chloride Hypertonicity Ophthalmic | SODIUM CHLORIDE | Rugby Laboratories | 7546770d-bc12-44b8-9fe0-fc3f5e1d12d1 | 2026-09-24 | Warnings | 451W47IQ8X |
| Sodium Chlorode Hypertonicity Ophthalmic Solution | SODIUM CHLORIDE | Rugby Laboratories | 822d25c0-71b3-421d-b702-4cded0c4ca32 | 2026-09-23 | Warnings | 451W47IQ8X |
| BURBLE | SODIUM CHLORIDE | LETS BURBLE, INC. | 17f48d4f-907c-3829-e063-6394a90ab202 | 2026-09-22 | Warnings | 451W47IQ8X |
| HEB Extra Strength Original Flavor | ALUMINUM HYDROXIDE AND MAGNESIUM CARBONATE | HEB | 7e1d9c13-f05f-4510-b60a-3101cb9fbad7 | 2026-09-18 | Warnings | 5QB0T2IUN0 |
| HEB Extra Strength Cool Mint | ALUMINUM HYDROXIDE AND MAGNESIUM CARBONATE | HEB | 855b7af0-cbb3-4c89-be2d-4048f8b0db57 | 2026-09-18 | Warnings | 5QB0T2IUN0 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.